This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

The Clinical Trials Industry’s Weekly News Update

WCG teams with AI specialist to speed recruitment and raise awareness

Share this article

WCG has teamed-up with tech firm Deep 6 AI to develop more effective and targeted recruitment methods.

The deal will aim to combine WCG’s relationship with more 3,300 research institutions and trial sites with Deep 6’s artificial intelligence technology which, the firm claims, which connects 28 million patients at 2,000 healthcare facilities.

Deep 6’s technology uses artificial intelligence (AI) concepts like natural language processing (NLP) and machine learning (ML) to analyze structured and unstructured data from multiple systems to match patients to clinical trials.

The overall goal of the collaboration is to enable clinical trials as a care alternative for more people and empower greater diversity among research participants according to WCG Nick Slack.

“As medical advances bring targeted therapies – especially in oncology – to smaller and more niche patient populations, clinical trials have become increasingly complex. Healthcare systems lack awareness of existing patients who could be matched to these studies and, similarly, research sponsors and their CRO partners lack the tools to locate eligible patients.

“Consequently, the vast majority of clinical trials fail to recruit enough participants, slowing down critical research and delaying access to life-saving treatments” Slack said.

Another aim is to accelerate recruitment for the sponsors and CROs WCG works with by raising awareness about studies according to Deep 6 CEO and founder Wout Brusselaers.

“The majority of patients and their physicians are unaware of clinical trials opportunities, which means finding an eligible patient can be like finding a needle in a haystack,” Brusselaers said, explaining the aim is to help trials connect with patients.

“This comprehensive solution will make it possible for sponsors and CROs to easily determine which sites are best suited to participate in a study because they can know in advance whether they can identify, recruit, and retain the right patients.

“This also provides a critical benefit to the sites in our network – they will know, before a trial opens, that they will be able to conduct an effective study. With such actionable information, there are huge advantages to those sites, sponsors, and CROs who choose to plug into our ecosystem.”

The partnership with Deep 6 follows just weeks after WCG launched its CRO Strategic Alliance Program, which grants access to a library of operations data to help contractors cut timelines and costs.

Image: Stock Photo Secrets

Share this article

Sign up for Clinical Insider email updates